dapsone has been researched along with edetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kashyap, A; Saha, K; Sehgal, VN | 1 |
| Roychowdhury, S; Svensson, CK; Vyas, PM | 1 |
1 review(s) available for dapsone and edetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dapsone and edetic acid
| Article | Year |
|---|---|
Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9).
Topics: Animals; Chloroquine; Clofazimine; Complement Activation; Complement System Proteins; Dapsone; Edetic Acid; Guinea Pigs; Hemolysis; Humans; Rats; Zymosan | 1992 |
Role of human cyclooxygenase-2 in the bioactivation of dapsone and sulfamethoxazole.
Topics: Arachidonic Acid; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Dapsone; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Hemin; Humans; Hydrogen Peroxide; Hydroxylamines; Protein Binding; Sulfamethoxazole | 2006 |